Option Care Health OPCH · NASDAQ
$31.21 +0.03% (+$0.01)
Summary
60 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 15% a year over the last 3 years.
- It bought back its own shares for $310.0M in the last fiscal year, 6.6% of its market value.
What to watch
- Out of every 100 USD of revenue, only 3.7 USD is left as net profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 22.3 USD for 1 USD of yearly profit. Over the last five years it was 28.0 USD on average.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 13% a year over 5 years. Over the last 3 years it grew by 13% a year. For the next fiscal year analysts expect revenue to grow by 1.9%. Earnings per share grew by 15% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyWhere 100 USD of revenue goes
- Cost of sales 82 USD
- Sales and administration 12 USD
- Taxes and other 2.3 USD
- Net profit 3.7 USD
Net profit, industry median (Medical - Care Facilities) 6.7 USD
Out of every 100 USD of revenue, 3.7 USD is left as net profit.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 3.7 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 6
- Hold 10
- Sell 0
Today's price within the analysts' price targets
The average target of $28.78 is 7.8% below today's price. 38% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Reportable Segment 100%
By region
The company reports no revenue by region.
Reportable Segment brings in 100% of revenue.
Segments in detail